China gives India competition in bulk drugs market

09/10/2013 | Business Standard (India)

China's exports of bulk drugs to India are growing at the rate of 30% annually, while Indian exporters are finding it difficult to enter the Chinese market, according to Indian pharmaceutical experts. Bulk drugs from China are growing in popularity because of price and availability, said Sunil Parekh of the global research company Crisil. Cheaper API imports from China are hurting domestic Indian API makers but may be a boon to generic drug companies.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI